IL-29/IL-28 Recombinant Rabbit mAb (SDT-1838-9-2)

產(chǎn)品型號：S0B3404

更新時間：2025-06-29

廠商性質(zhì)：生產(chǎn)廠家

訪問量：30

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

斯達(dá)特HbA1c配對抗體：為糖尿病研究與臨床診斷提供原料

PD-L1 IHC抗體

IHC腫瘤標(biāo)志物 | 常見胃癌和結(jié)直腸癌診斷

p16/Ki-67雙染：子宮頸癌前病變診斷的精準(zhǔn)之道

產(chǎn)品介紹

IL-28A, IL-28B, and IL-29, also named interferon-lambda 2 （IFN-lambda 2）, IFN-lambda 3, and IFN-lambda 1, respectively, are newly identified class II cytokine receptor ligands that are distantly related to members of the IL-10 family （11-13% a.a. sequence identity） and the type IIFN family （15-19 % a.a. sequence identity）. The expression of IL-28A, B, and IL-29 is induced by virus infection or double-stranded RNA. All three cytokines exert bioactivities that overlap those of type I IFNs, including antiviral activity and upregulation of MHC class I antigen expression. The three proteins signal through the same heterodimeric receptor complex that is composed of the IL-10 receptor lambda （IL-10 R beta） and a novel IL-28 receptor alpha （IL-28 R alpha, also known as IFN-lambda R1）. Ligand binding to the receptor complex induces Jak kinase activation and STAT1 and STAT2 tyrosine phosphorylation.

上一個：S0B3402IL-29/IL-28 Recombinant Rabbit mAb (SDT-1838-32)